Apple defeats bid for new Apple Watch import ban at US trade tribunal

The Art of the Technical Pivot: How Hardware Giants Dodge Patents

When a multi-billion dollar product faces an import ban, the response is rarely to simply give up. Instead, companies often engage in what industry experts call a “technical pivot.” The recent battle between Apple and Masimo serves as a masterclass in this strategy.

To avoid a ban on the Apple Watch Series 9 and Ultra 2, Apple didn’t just remove the blood-oxygen feature. they redesigned the entire process. By moving the data processing from the watch itself to the paired iPhone, Apple successfully argued that the new version of the technology did not infringe on Masimo’s patents.

This trend suggests a future where health-tracking features become more modular. We may see more devices that act as simple data collectors, while the “intelligence” and analysis are handled by a separate hub or cloud service to navigate complex intellectual property landscapes.

MedTech vs. Big Tech: The Struggle for Health Data Control

The conflict between Apple and Masimo—now owned by Danaher—highlights a growing tension. Specialized medical technology companies possess deep, proprietary expertise in areas like pulse-oximetry, while Big Tech companies possess the scale to bring these features to millions of consumers.

The allegations in this case travel beyond simple patent disputes. Masimo accused Apple of poaching key engineers to gain access to proprietary technology for measuring blood oxygen levels. This points to a trend of “talent wars” where the acquisition of human capital is as strategic as the acquisition of patents.

As wearables evolve into medical-grade devices, we can expect more aggressive litigation from medtech firms seeking to protect their research and development investments from larger consumer electronics firms.

The ITC and the Power of the Import Ban

The utilize of the International Trade Commission (ITC) has become a powerful weapon in corporate warfare. Unlike standard lawsuits that seek monetary damages, the ITC can issue exclusion orders that stop products from even entering the country.

Apple experienced this firsthand in December 2023 when the ITC blocked imports of specific watch models. While Apple eventually cleared a major hurdle when the commission declined to review a ruling that their redesigned watches were non-infringing, the threat of an import ban remains a potent tool for smaller companies to force concessions from giants.

This trend indicates that the “exclusion order” is becoming a preferred first strike in patent disputes, as it creates immediate revenue loss and supply chain chaos, providing the plaintiff with significant leverage.

Future Outlook for Health Wearables

Looking ahead, the industry is likely to see a shift toward more transparent licensing agreements. Rather than spending six years in a “relentless legal campaign,” as Apple described it, companies may move toward preemptive partnerships to ensure health features reach the market faster.

the role of U.S. Customs and Border Protection will remain pivotal, as they are the final gatekeepers deciding if a “redesign” is sufficient to bypass an existing ban.

Frequently Asked Questions